Nektar Therapeutics – Investors and Politicians Who Own It
NKTR, 2 share classes and securities
Investors who own it
3 tracked investors, $204.9M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Mark LampertBVF Partners, Q2 2026 | $166.9M | 4.27% |
David KroinDeep Track Capital, Q2 2026 | $20.9M | 0.30% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $17M | 0.78% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Farallon Capital Management | Sold out | 0 |
| Mark Lampert | Added +22% | 1,559,595 |
| Daniel Schneeberger | Added +0.0% | 72,031 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
| Politician | Action | Traded |
|---|---|---|
Josh GottheimerJointD-NJ · House | Sold$1K–$15K | Jun 21, 2018disclosed Oct 2, 2018 |
Josh GottheimerJointD-NJ · House | Bought$1K–$15K | Jun 6, 2018disclosed Oct 2, 2018 |